Guardant Health (GH) Competitors $31.67 +0.54 (+1.73%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends GH vs. FMS, HIMS, OPCH, SHC, VCYT, BTSG, LFST, SGRY, CON, and PRVAShould you be buying Guardant Health stock or one of its competitors? The main competitors of Guardant Health include Fresenius Medical Care (FMS), Hims & Hers Health (HIMS), Option Care Health (OPCH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry. Guardant Health vs. Fresenius Medical Care Hims & Hers Health Option Care Health Sotera Health Veracyte BrightSpring Health Services LifeStance Health Group Surgery Partners Concentra Group Holdings Parent Privia Health Group Guardant Health (NASDAQ:GH) and Fresenius Medical Care (NYSE:FMS) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, community ranking, risk and analyst recommendations. Which has higher earnings and valuation, GH or FMS? Fresenius Medical Care has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardant Health$692.26M5.65-$479.45M-$4.24-7.47Fresenius Medical Care$19.24B0.70$540.07M$1.2118.85 Does the MarketBeat Community believe in GH or FMS? Fresenius Medical Care received 140 more outperform votes than Guardant Health when rated by MarketBeat users. However, 70.07% of users gave Guardant Health an outperform vote while only 54.68% of users gave Fresenius Medical Care an outperform vote. CompanyUnderperformOutperformGuardant HealthOutperform Votes28170.07% Underperform Votes12029.93% Fresenius Medical CareOutperform Votes42154.68% Underperform Votes34945.32% Does the media refer more to GH or FMS? In the previous week, Guardant Health had 10 more articles in the media than Fresenius Medical Care. MarketBeat recorded 14 mentions for Guardant Health and 4 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.06 beat Guardant Health's score of 0.56 indicating that Fresenius Medical Care is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 7 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fresenius Medical Care 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is GH or FMS more profitable? Fresenius Medical Care has a net margin of 3.43% compared to Guardant Health's net margin of -74.02%. Fresenius Medical Care's return on equity of 6.04% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Guardant Health-74.02% -1,200.44% -29.88% Fresenius Medical Care 3.43%6.04%2.69% Do insiders and institutionals have more ownership in GH or FMS? 92.6% of Guardant Health shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care shares are held by institutional investors. 5.5% of Guardant Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more risk and volatility, GH or FMS? Guardant Health has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500. Do analysts prefer GH or FMS? Guardant Health presently has a consensus price target of $40.60, indicating a potential upside of 28.20%. Fresenius Medical Care has a consensus price target of $24.30, indicating a potential upside of 6.53%. Given Guardant Health's stronger consensus rating and higher probable upside, research analysts clearly believe Guardant Health is more favorable than Fresenius Medical Care.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardant Health 0 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 3.00Fresenius Medical Care 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryGuardant Health and Fresenius Medical Care tied by winning 9 of the 18 factors compared between the two stocks. Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. Get Guardant Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GH vs. The Competition Export to ExcelMetricGuardant HealthMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.85B$2.93B$5.12B$9.07BDividend YieldN/A15.63%4.91%4.22%P/E Ratio-7.4716.0291.3417.19Price / Sales5.65284.461,117.70116.80Price / CashN/A472.1142.6437.86Price / Book23.635.194.794.78Net Income-$479.45M-$32.86M$120.07M$225.60M7 Day Performance-8.89%-3.01%-1.90%-1.23%1 Month Performance1.87%2.96%11.45%3.37%1 Year Performance16.01%12.37%30.63%16.58% Guardant Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GHGuardant Health4.115 of 5 stars$31.67+1.7%$40.60+28.2%+25.6%$3.85B$692.26M-7.471,779FMSFresenius Medical Care3.4922 of 5 stars$23.97+1.4%$24.30+1.4%+11.4%$14.07B$19.24B19.791,358News CoveragePositive NewsHIMSHims & Hers Health3.3819 of 5 stars$30.98+3.2%$21.43-30.8%+214.3%$6.77B$872M70.251,046Analyst ForecastInsider TradeNews CoverageOPCHOption Care Health4.8671 of 5 stars$23.46-0.1%$30.14+28.5%-29.9%$3.99B$4.78B19.747,802Positive NewsSHCSotera Health3.5856 of 5 stars$12.99-1.2%$16.08+23.8%-20.0%$3.68B$1.05B52.603,000Positive NewsVCYTVeracyte4.0331 of 5 stars$43.25+0.1%$41.13-4.9%+49.0%$3.35B$361.05M-288.13790Positive NewsBTSGBrightSpring Health Services2.311 of 5 stars$18.83+1.5%$18.50-1.8%N/A$3.28B$10.59B-71.3835,000Analyst ForecastLFSTLifeStance Health Group1.6908 of 5 stars$7.77+8.4%$8.70+12.0%-0.3%$2.97B$1.21B-29.509,325Positive NewsGap UpSGRYSurgery Partners3.2423 of 5 stars$22.01+8.1%$36.56+66.1%-33.8%$2.80B$2.74B-42.4213,500CONConcentra Group Holdings ParentN/A$21.53+5.0%$28.50+32.4%N/A$2.74B$1.88B0.0011,000Gap UpPRVAPrivia Health Group2.8961 of 5 stars$21.42+2.2%$24.80+15.8%-12.6%$2.57B$1.66B209.621,102 Related Companies and Tools Related Companies Fresenius Medical Care Alternatives Hims & Hers Health Alternatives Option Care Health Alternatives Sotera Health Alternatives Veracyte Alternatives BrightSpring Health Services Alternatives LifeStance Health Group Alternatives Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives Privia Health Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GH) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardant Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardant Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
